Home » Health Care

Press Releases

BIO Submits Comments on FDA Draft Guidances on Biosimilars
April 17 2012

The Biotechnology Industry Organization (BIO) submitted comments yesterday to the U.S. Food...

BIO Testifies on Importance of Timely Passage of BsUFA and PDUFA
March 29 2012

Sara Radcliffe, Executive Vice President of Health at the Biotechnology Industry Organization...

TREAT Act Offers Renewed Hope for Patients
February 15 2012

The bill will modernize the FDA and accelerate patient access to cures and new treatments.

Release of FDA Guidance for Biosimilars Pathway Marks Important Step Forward, Says BIO
February 9 2012

BIO President and CEO Jim Greenwood issued the following statement regarding the newly...

Representative Upton Honored as BIO Legislator of the Year
May 4 2011

BIO announces selection of Congressman Fred Upton (R-MI) as Legislator of the Year for 2010 -...

Congressman Price Honored as BIO Legislator of the Year
May 4 2011

The Biotechnology Industry Organization (BIO) announced today its selection of Representative...

Representative Capuano Honored as BIO Legislator of the Year
May 4 2011

The Biotechnology Industry Organization (BIO) announced today its selection of Congressman...

Final Biosimilars Pathway Must Make Patient Safety and Incentives For Continued Innovation Top Priorities, Says BIO
November 3 2010
New BIO Report Highlights Value of Biotechnology to Individuals and Society
May 4 2010

A new report issued by the Biotechnology Industry Organization underscores how biotechnology...

Letters, Testimony & Comments

BIO Comments on Colombia Biologics and Biosimilars Regulations
February 22 2013
BIO commends the government of Colombia for taking steps towards developing regulatory requirements for the registry of medicines of...
Letter Supporting Florida House Bill 365; Pertaining to requirements for pharmacist to dispense substitute biological product
February 1 2013
Representative Matt Hudson Florida House of Representatives 402 South Monroe Street Tallahassee, FL 32399 Dear Representative Hudson...
Statement in Support of Virginia H.B. 1422
January 10 2013
In December 2012, Virginia House Delegate John M. O'Bannon, III introduced the Interchangeable biosimilar biological products bill (H...
BIO Comments on EMA Guideline on Biosimilar Quality Issues
November 30 2012
  The Biotechnology Industry Organization (BIO) thanks the European Medicines Agency (EMA or Agency) for the opportunity to submit...
Biosimilar Patent Certification: University Associations Ask FDA to Not Undermine Their Patent Rights
November 5 2012
Dear Commissioner Hamburg: We are writing on behalf of the following higher education associations in consideration of issues raised...
More Letters, Testimony & Comments →

Press Releases

BIO Submits Comments on FDA Draft Guidances on Biosimilars
April 17 2012
Washington, D.C. (April 17, 2012) – The Biotechnology Industry Organization (BIO) submitted comments yesterday...
BIO Testifies on Importance of Timely Passage of BsUFA and PDUFA
March 29 2012
Washington, D.C. (March 29, 2012) – Sara Radcliffe, Executive Vice President of Health at the Biotechnology...
TREAT Act Offers Renewed Hope for Patients
February 15 2012
Washington, DC (February 15, 2012) – Today, the Biotechnology Industry Organization (BIO) praised Sen. Kay...
Release of FDA Guidance for Biosimilars Pathway Marks Important Step Forward, Says BIO
February 9 2012
Patient Safety Must Remain Top Priority Washington, D.C. (February 9, 2012) — Biotechnology Industry...
Representative Upton Honored as BIO Legislator of the Year
May 4 2011
WASHINGTON, D.C. (Tuesday, May 04, 2011) - The Biotechnology Industry Organization (BIO) announced today its...
More Press Releases →